Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union

Publisher: John Wiley & Sons Inc

E-ISSN: 2157-6580|7|1|146-154

ISSN: 2157-6564

Source: STEM CELLS Translational Medicine, Vol.7, Iss.1, 2018-01, pp. : 146-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract